The revenue stands at ₹3,302.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.90 per cent from ₹3,178.00 crore. This corresponds to a year-on-year *(YoY) growth of 14.30 per cent.
Operating Profit stands at ₹21.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 10.53 per cent from ₹19.00 crore. This corresponds to a year-on-year *(YoY) decline of 56.25 per cent.
PBDT stands at ₹404.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.32 per cent from ₹391.00 crore. This corresponds to a year-on-year *(YoY) decline of 0.49 per cent.
Profit Before Tax stands at ₹791.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 7.18 per cent from ₹738.00 crore. This corresponds to a year-on-year *(YoY) growth of 19.67 per cent.
Net Profit stands at ₹604.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 10.22 per cent from ₹548.00 crore. This represents a 33.33 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Torrent Pharma. | 1.89% | 2.53% | 3.18% | 6.57% | 12.28% | 32.99% |
| Sun Pharma.Inds. | 0.17% | 0.31% | -1.69% | -1.40% | 5.27% | 0.82% |
| Divi's Lab. | 0.63% | 0.30% | -5.14% | -5.59% | 3.25% | 3.16% |
| Cipla | -0.03% | 0.71% | -8.45% | -11.70% | -11.74% | -7.43% |
| Dr Reddy's Labs | -1.19% | 0.96% | 3.41% | 2.27% | 2.99% | 3.39% |
| Lupin | -0.37% | -0.68% | 0.58% | 8.18% | 13.30% | 8.76% |
Executive Chairman : Samir Mehta
Independent Director : Ameera Shah
Independent Director : Nayantara Bali
Managing Director : Aman Mehta
Independent Director : Manish Choksi
Company Sec. & Compli. Officer : Chintan Trivedi
Independent Director : Nikhil Khattau
Non Executive Director : Jindal Mehta